Jordan Defends Drug Quality Against Iraqi Attack

3 March 1997

Jordan's drugmakers have joined forces to defend the internationalstandard and specifications of their products amid the competitive struggle to secure Iraqi orders under the oil-for-food-and-drugs deal with the United Nations.

The controversy began when Iraqi Trade Minister Mahdi Saleh said Jordanian drug firms had to upgrade quality if they expected orders from Iraq. Jordanian firms have supplied drugs and hospital equipment to Iraq since 1991 in exchange for Iraqi crude oil. But, said Mr Saleh, while Iraq could still order the drugs under the current framework agreement, any orders under the UN deal would come only if quality improved. A UN committee had to approve every import contract, and price and quality would be scrutinized.

Wasef Azar, chairman of the Arab Center for Pharmaceutical and Chemical Industries Co, said Mr Saleh was "not really complaining" but "trying to foster competition" among Jordanian firms. He said Jordanian drugs were high-quality and competitively priced, and suggested that the industry adopt a joint strategy to secure Iraqi orders and raise its share of the Iraqi market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight